ProterixBio
Signal active
Organization
Contact Information
Overview
Developer of proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. The company is focused on addressing the unmet need for tools to provide a real-time, biological assessment of a patient’s disease state. ProterixBio's products will enable health care providers to better manage their patients and avoid unnecessary hospitalizations, leading to improved outcomes and reduced health care costs.
It was founded in 2002 and headquartered in Billerica, Massachusetts.
About
Industries
Biotechnology, Pharmaceutical, Health Diagnostics
Founded
2002
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ProterixBio headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $10.8B in funding across 108 round(s). With a team of 11-50 employees, ProterixBio is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - ProterixBio, raised $20.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
2
Lead Investors
0
Total Funding Amount
$100.3M
Details
5
ProterixBio has raised a total of $100.3M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2005 | Early Stage Venture | 3.0M | ||
| 2004 | Early Stage Venture | 2.0M | ||
| 2013 | Private Equity | 18.8M | ||
| 2010 | Late Stage Venture | 25.0M |
Investors
ProterixBio is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| ProterixBio | - | FUNDING ROUND - ProterixBio | 25.0M |
| MF Capital | - | FUNDING ROUND - MF Capital | 25.0M |
| ProterixBio | - | FUNDING ROUND - ProterixBio | 20.7M |
| New York Angels | - | FUNDING ROUND - New York Angels | 20.7M |
Recent Activity
There is no recent news or activity for this profile.